These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 12602800)
1. Search for new non-nucleoside inhibitors of HIV-1 reverse transcriptase (HIV-1 RT). Brzezińska E; Glinka R Acta Pol Pharm; 2002; 59(5):379-86. PubMed ID: 12602800 [TBL] [Abstract][Full Text] [Related]
2. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis. Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors. Xu B; Sun Y; Guo Y; Cao Y; Yu T Bioorg Med Chem; 2009 Apr; 17(7):2767-74. PubMed ID: 19269831 [TBL] [Abstract][Full Text] [Related]
4. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors. Rawal RK; Prabhakar YS; Katti SB; De Clercq E Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576 [TBL] [Abstract][Full Text] [Related]
5. Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants. Su DS; Lim JJ; Tinney E; Wan BL; Young MB; Anderson KD; Rudd D; Munshi V; Bahnck C; Felock PJ; Lu M; Lai MT; Touch S; Moyer G; Distefano DJ; Flynn JA; Liang Y; Sanchez R; Prasad S; Yan Y; Perlow-Poehnelt R; Torrent M; Miller M; Vacca JP; Williams TM; Anthony NJ Bioorg Med Chem Lett; 2009 Sep; 19(17):5119-23. PubMed ID: 19631528 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular modeling studies of N-aryl-2-arylthioacetamides as non-nucleoside HIV-1 reverse transcriptase inhibitors. Xiaohe Z; Yu Q; Hong Y; Xiuqing S; Rugang Z Chem Biol Drug Des; 2010 Oct; 76(4):330-9. PubMed ID: 20731670 [TBL] [Abstract][Full Text] [Related]
7. Pyrazole NNRTIs 1: design and initial optimisation of a novel template. Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880 [TBL] [Abstract][Full Text] [Related]
8. Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase. Sweeney ZK; Dunn JP; Li Y; Heilek G; Dunten P; Elworthy TR; Han X; Harris SF; Hirschfeld DR; Hogg JH; Huber W; Kaiser AC; Kertesz DJ; Kim W; Mirzadegan T; Roepel MG; Saito YD; Silva TM; Swallow S; Tracy JL; Villasenor A; Vora H; Zhou AS; Klumpp K Bioorg Med Chem Lett; 2008 Aug; 18(15):4352-4. PubMed ID: 18632268 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Mokale SN; Lokwani D; Shinde DB Bioorg Med Chem; 2012 May; 20(9):3119-27. PubMed ID: 22480850 [TBL] [Abstract][Full Text] [Related]
10. Thiourea-based non-nucleoside inhibitors of HIV reverse transcriptase as bifunctional organocatalysts in the asymmetric Strecker synthesis. Tsogoeva SB; Hateley MJ; Yalalov DA; Meindl K; Weckbecker C; Huthmacher K Bioorg Med Chem; 2005 Oct; 13(19):5680-5. PubMed ID: 15964195 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of N-acetyl-beta-aryl-1,2-didehydroethylamines as new HIV-1 RT inhibitors in vitro. Cheng P; Jiang ZY; Wang RR; Zhang XM; Wang Q; Zheng YT; Zhou J; Chen JJ Bioorg Med Chem Lett; 2007 Aug; 17(16):4476-80. PubMed ID: 17574419 [TBL] [Abstract][Full Text] [Related]
12. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain. Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C Chem Biodivers; 2009 Apr; 6(4):561-8. PubMed ID: 19353537 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity. Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers M; Van Aken KJ; Arnold E; Das K; Kilonda A; Hoornaert GJ; Compernolle F; Cegla M; Azzam RA; Andries K; de Béthune MP; Azijn H; Pauwels R; Lewi PJ; Janssen PA J Med Chem; 2005 Mar; 48(6):1910-8. PubMed ID: 15771435 [TBL] [Abstract][Full Text] [Related]
14. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors. Lu X; Chen Y; Guo Y; Liu Z; Shi Y; Xu Y; Wang X; Zhang Z; Liu J Bioorg Med Chem; 2007 Dec; 15(23):7399-407. PubMed ID: 17870545 [TBL] [Abstract][Full Text] [Related]
15. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1. Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346 [TBL] [Abstract][Full Text] [Related]
16. Structure-based design, synthesis, and in vitro assay of novel nucleoside analog inhibitors against HIV-1 reverse transcriptase. Liu X; Xie W; Huang RH Bioorg Med Chem Lett; 2005 Aug; 15(16):3775-7. PubMed ID: 15993595 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of 1-(3-phthalimido-2-oxobutyl)-4-substituted- phenylpiperazines and their anti-HIV reverse transcriptase activity. Chen X; Wang L; Zhao ZZ; Zhang XQ; Chen XH; Chen HS Yao Xue Xue Bao; 2002 May; 37(5):343-7. PubMed ID: 12579837 [TBL] [Abstract][Full Text] [Related]
18. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2). Lavecchia A; Costi R; Artico M; Miele G; Novellino E; Bergamini A; Crespan E; Maga G; Di Santo R ChemMedChem; 2006 Dec; 1(12):1379-90. PubMed ID: 17089434 [TBL] [Abstract][Full Text] [Related]